325 related articles for article (PubMed ID: 26038993)
1. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
Pár A; Vincze Á; Pár G
Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
Kim JH; Kim MN; Han KH; Kim SU
Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
Castera L
Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
Sharma S; Khalili K; Nguyen GC
World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
[TBL] [Abstract][Full Text] [Related]
8. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
[TBL] [Abstract][Full Text] [Related]
9. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
Castera L; Bedossa P
Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C and liver fibrosis.
Sebastiani G; Gkouvatsos K; Pantopoulos K
World J Gastroenterol; 2014 Aug; 20(32):11033-53. PubMed ID: 25170193
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
[TBL] [Abstract][Full Text] [Related]
12. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.
Fransen van de Putte D; Blom R; van Soest H; Mundt M; Verveer C; Arends J; de Knegt RE; Mauser-Bunschoten E; van Erpecum K
Ann Hepatol; 2011; 10(4):469-76. PubMed ID: 21911887
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.
de Lédinghen V; Vergniol J; Barthe C; Foucher J; Chermak F; Le Bail B; Merrouche W; Bernard PH
Aliment Pharmacol Ther; 2013 May; 37(10):979-88. PubMed ID: 23557139
[TBL] [Abstract][Full Text] [Related]
14. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
Castera L
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
[TBL] [Abstract][Full Text] [Related]
15. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients.
Cho HJ; Seo YS; Lee KG; Hyun JJ; An H; Keum B; Kim JH; Yim HJ; Jeen YT; Lee HS; Chun HJ; Um SH; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2011 Mar; 26(3):492-500. PubMed ID: 21332545
[TBL] [Abstract][Full Text] [Related]
16. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
17. Viscoelasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis C patients after liver transplantation.
Kamphues C; Klatt D; Bova R; Yahyazadeh A; Bahra M; Braun J; Klauschen F; Neuhaus P; Sack I; Asbach P
Rofo; 2012 Nov; 184(11):1013-9. PubMed ID: 22893489
[TBL] [Abstract][Full Text] [Related]
18. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
Sebastiani G; Alberti A
J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive assessment of liver fibrosis in chronic hepatitis B.
Branchi F; Conti CB; Baccarin A; Lampertico P; Conte D; Fraquelli M
World J Gastroenterol; 2014 Oct; 20(40):14568-80. PubMed ID: 25356021
[TBL] [Abstract][Full Text] [Related]
20. Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C.
Crisan D; Radu C; Grigorescu MD; Lupsor M; Feier D; Grigorescu M
J Gastrointestin Liver Dis; 2012 Dec; 21(4):375-82. PubMed ID: 23256120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
